The new guide starts with a step-by-step presentation of the IHC workflow, followed by an IHC Selection Guide, which helps users specify the right tool for each step in the workflow. The guide gives an historical review of the development of IHC technology breakthroughs and then presents easy-to-use charts and information on detection system choices, multiple antigen labeling options and counterstaining methodology. Also included is helpful information on blocking background signal, the use of secondary and tertiary reagents and the importance of choosing the right mounting media and accessory reagents. The visually striking guide is illustrated throughout with images produced using Vector Laboratories’ technology.
“The use of IHC has grown tremendously in the last 50 years or so, as new methods for labeling antibodies and retrieving antigens from stored samples have been developed,” explains Harjit Kullar, vice president of marketing for Maravai LifeSciences. “Today IHC is used in a wide range of biomedical research applications. With this guide, we provide researchers with visually interesting and essential content on how to get useful and impressive images from their IHC efforts.”
About Vector Laboratories
Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools to its customers for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, U.K., the company maintains a network of more than 40 distributors across the globe. A privately held company, Vector Laboratories was acquired by Maravai LifeSciences in 2016.